130 related articles for article (PubMed ID: 7772068)
1. Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells.
Chen Y; Morimoto S; Kitano S; Koh E; Fukuo K; Jiang B; Chen S; Yasuda O; Hirotani A; Ogihara T
Atherosclerosis; 1995 Jan; 112(1):69-76. PubMed ID: 7772068
[TBL] [Abstract][Full Text] [Related]
2. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats.
Rosen B; Barg J; Zimlichman R
Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1243-51. PubMed ID: 10619588
[TBL] [Abstract][Full Text] [Related]
3. Nonselective cation currents regulate membrane potential of rabbit coronary arterial cell: modulation by lysophosphatidylcholine.
Terasawa K; Nakajima T; Iida H; Iwasawa K; Oonuma H; Jo T; Morita T; Nakamura F; Fujimori Y; Toyo-oka T; Nagai R
Circulation; 2002 Dec; 106(24):3111-9. PubMed ID: 12473560
[TBL] [Abstract][Full Text] [Related]
4. Marked dissociation between intracellular Ca2+ level and contraction on exposure of rat aorta to lysophosphatidylcholine.
Suenaga H; Kamata K
Eur J Pharmacol; 1999 Aug; 378(2):177-86. PubMed ID: 10478630
[TBL] [Abstract][Full Text] [Related]
5. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells.
Koh E; Morimoto S; Tomita J; Rakugi H; Jiang B; Inoue T; Nabata T; Fukuo K; Ogihara T
J Cardiovasc Pharmacol; 1994 Feb; 23(2):175-9. PubMed ID: 7511744
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of lysophosphatidylcholine-induced Ca2+ response in human neuroblastoma SH-SY5Y cells.
Li XH; Wu YJ
Life Sci; 2007 Feb; 80(9):886-92. PubMed ID: 17157326
[TBL] [Abstract][Full Text] [Related]
7. Role of calcium in angiotensin II-induced prostaglandin release and DNA synthesis in rat vascular smooth muscle cells.
Catalioto RM; Renzetti AR; Criscuoli M; Morbidelli L; Subissi A
J Cardiovasc Pharmacol; 1996 Feb; 27(2):195-200. PubMed ID: 8720417
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Cardiovasc Pharmacol; 2002 Mar; 39(3):449-59. PubMed ID: 11862125
[TBL] [Abstract][Full Text] [Related]
9. Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Hypertens; 2001 Jun; 19(6):1065-73. PubMed ID: 11403355
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Koba S; Katagiri T; Benedict CR
Circulation; 2001 Mar; 103(10):1440-5. PubMed ID: 11245650
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine increases C-type natriuretic peptide expression in human vascular smooth muscle cells via membrane distortion.
Mendonça MC; Rezende A; Doi SQ; Sellitti DF
Vascul Pharmacol; 2009 Jul; 51(1):29-36. PubMed ID: 19275966
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor and angiotensin II cause increases in cytosolic free calcium by different mechanisms in vascular smooth muscle cells.
Roe MW; Hepler JR; Harden TK; Herman B
J Cell Physiol; 1989 Apr; 139(1):100-8. PubMed ID: 2708448
[TBL] [Abstract][Full Text] [Related]
13. Increase by lysophosphatidylcholines of smooth muscle Ca2+ sensitivity in alpha-toxin-permeabilized small mesenteric artery from the rat.
Jensen PE; Ohanian J; Stausbøl-Grøn B; Buus NH; Aalkjaer C
Br J Pharmacol; 1996 Mar; 117(6):1238-44. PubMed ID: 8882621
[TBL] [Abstract][Full Text] [Related]
14. Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.
Nie L; Mogami H; Kanzaki M; Shibata H; Kojima I
Mol Pharmacol; 1996 Oct; 50(4):763-9. PubMed ID: 8863820
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells.
Yokoyama K; Ishibashi T; Ohkawara H; Kimura J; Matsuoka I; Sakamoto T; Nagata K; Sugimoto K; Sakurada S; Maruyama Y
Circulation; 2002 Feb; 105(8):962-7. PubMed ID: 11864926
[TBL] [Abstract][Full Text] [Related]
16. Involvement of erythropoietin-induced cytosolic free calcium mobilization in activation of mitogen-activated protein kinase and DNA synthesis in vascular smooth muscle cells.
Akimoto T; Kusano E; Ito C; Yanagiba S; Inoue M; Amemiya M; Ando Y; Asano Y
J Hypertens; 2001 Feb; 19(2):193-202. PubMed ID: 11212961
[TBL] [Abstract][Full Text] [Related]
17. Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide.
Watanabe T; Takahashi K; Kanome T; Hongo S; Miyazaki A; Koba S; Katagiri T; Pakara R; Benedict CR
Hypertens Res; 2006 Oct; 29(10):821-31. PubMed ID: 17283870
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells.
Watanabe T; Pakala R; Katagiri T; Benedict CR
Circulation; 2001 Jul; 104(1):16-8. PubMed ID: 11435331
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma.
Woodley SL; Ikenouchi H; Barry WH
J Mol Cell Cardiol; 1991 Jun; 23(6):671-80. PubMed ID: 1658342
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by lysophosphatidylcholine of nitric oxide production in interleukin 1 beta-stimulated vascular smooth muscle cells.
Okamoto Y; Kawahara Y; Yokoyama M
Kobe J Med Sci; 1998 Aug; 44(4):169-89. PubMed ID: 10352496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
